Leukotriene C4 is the major trigger of stress-induced oxidative DNA damage

Endoplasmic reticulum (ER) stress and major chemotherapeutic agents damage DNA by generating reactive oxygen species (ROS). Here we show that ER stress and chemotherapy induce leukotriene C 4 (LTC 4 ) biosynthesis by transcriptionally upregulating and activating the enzyme microsomal glutathione-S-t...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 6; no. 1; p. 10112
Main Authors Dvash, Efrat, Har-Tal, Michal, Barak, Sara, Meir, Ofir, Rubinstein, Menachem
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 11.12.2015
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Endoplasmic reticulum (ER) stress and major chemotherapeutic agents damage DNA by generating reactive oxygen species (ROS). Here we show that ER stress and chemotherapy induce leukotriene C 4 (LTC 4 ) biosynthesis by transcriptionally upregulating and activating the enzyme microsomal glutathione-S-transferase 2 (MGST2) in cells of non-haematopoietic lineage. ER stress and chemotherapy also trigger nuclear translocation of the two LTC 4 receptors. Acting in an intracrine manner, LTC 4 then elicits nuclear translocation of NADPH oxidase 4 (NOX4), ROS accumulation and oxidative DNA damage. Mgst 2 deficiency, RNAi and LTC 4 receptor antagonists abolish ER stress- and chemotherapy-induced ROS and oxidative DNA damage in vitro and in mouse kidneys. Cell death and mouse morbidity are also significantly attenuated. Hence, MGST2-generated LTC 4 is a major mediator of ER stress- and chemotherapy-triggered oxidative stress and oxidative DNA damage. LTC 4 inhibitors, commonly used for asthma, could find broad clinical use in major human pathologies associated with ER stress-activated NOX4. Chemotherapeutic agents elicit ER and oxidative stress as part of their mode of action. Here the authors show that chemotherapy and ER stress trigger MGST2-based biosynthesis of LTC 4 , whose inhibition abolishes chemotherapy- and ER stress-triggered oxidative stress and DNA damage, resulting in the attenuation of cell death.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: Monsanto, Rehovot 7612101, Israel.
ISSN:2041-1723
2041-1723
DOI:10.1038/ncomms10112